Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594152 · ClinicalTrials.gov registry record · Phase 3
Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
A Phase 3 study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 71
- Enrollment target
NCT00594152 is a Phase 3 study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 71 participants.
The verdict
NCT00594152, a Phase 3 study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 71 participants
- Enrollment target
Study Summary
Investigators with the goal of optimizing glycemic and blood pressure control saw type 1 diabetic patients weekly. A control group received 3-4 subcutaneous insulin injections per day; an intravenous insulin pulsed infusion group received, in addition, three one hour infusions in a pulsatile fashion over one eight hour period each week. Patients were followed for 12 months with periodic testing of renal function by repeated blood and urinary analyses; diabetes control by blood testing and diabetes impact measurement score; cardiac and autonomic function by echocardiography, 24 hour electrocardiographic testing; and visual changes with repeated fundus photography. The study hypothesis was that correction of respiratory quotient would correct the defect leading to microvascular complications of diabetes (Type 1).
Interventions
- DRUG CIIIT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 1993-01 |
| Est. Completion | 1995-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00594152
The ClinicalTrials.gov registry entry for NCT00594152 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CIIIT is the first listed.
NCT00594152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00594152 about?
NCT00594152 is a clinical study titled "Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)". Investigators with the goal of optimizing glycemic and blood pressure control saw type 1 diabetic patients weekly. A control group received 3-4 subcutaneous insulin injections per day; an intravenous insulin pulsed infusion group received, in addition, three one hour infusions in a pulsatile fashion...
What is the current status of trial NCT00594152?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 71 participants. The study started on 1993-01. Estimated completion is 1995-01.
What interventions are being tested in trial NCT00594152?
The interventions under investigation include: CIIIT (DRUG).
Who is sponsoring clinical trial NCT00594152?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.